Alison Bauerlein - 05 Jan 2026 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Signature
/s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein
Issuer symbol
SGHT
Transactions as of
05 Jan 2026
Net transactions value
-$157,366
Form type
4
Filing time
06 Jan 2026, 19:03:09 UTC
Previous filing
13 Nov 2025
Next filing
05 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bauerlein Alison Chief Operating Officer C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK /s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein 06 Jan 2026 0001596080

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGHT Common Stock Sale $85,207 -10,896 -1.8% $7.82 609,630 05 Jan 2026 Direct F1, F2
transaction SGHT Common Stock Sale $72,160 -9,647 -1.6% $7.48 599,983 06 Jan 2026 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
F2 Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.39 to $7.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.